Sanofi
SNY
737 hedge funds and large institutions have $10.1B invested in Sanofi in 2026 Q1 according to their latest regulatory filings, with 103 funds opening new positions, 300 increasing their positions, 212 reducing their positions, and 102 closing their positions.
42% more repeat investments, than reductions
Existing positions increased: 300 | Existing positions reduced: 212
1% more first-time investments, than exits
New positions opened: 103 | Existing positions closed: 102
0.42% less ownership
Funds ownership: 9.08% → 8.66% (-0.42%)
2% less funds holding
Funds holding: 754 → 737 (-17)
7% less capital invested
Capital invested by funds: $10.8B → $10.1B (-$714M)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
16% less call options, than puts
Call options by funds: $96.6M | Put options by funds: $115M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$159M |
| 2 |
Millennium Management
New York
|
+$154M |
| 3 |
JP Morgan Chase
New York
|
+$121M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$108M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$96.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dodge & Cox
San Francisco,
California
|
-$1.26B |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$142M |
| 3 |
Natixis Advisors
Boston,
Massachusetts
|
-$110M |
| 4 |
BlackRock
New York
|
-$101M |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$98.4M |
SNY Hedge Fund Activity: Q1 2026 in Review
737 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q1 2026, worth a combined $10.1B — down 6.6% from $10.8B a quarter earlier.
Buyers outnumbered sellers: 103 funds opened new SNY positions and 102 closed out — a net gain of 1 holder — while 300 added to existing stakes and 212 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $159M. The largest seller was Dodge & Cox, cutting an estimated $1.26B.
- 737 institutional investors held Sanofi (SNY) as of Q1 2026, down from 754 in Q4 2025.
- Funds reported $10.1B of Sanofi stock for Q1 2026, down 6.6% quarter-over-quarter.
- 103 funds opened new Sanofi positions in Q1 2026 and 102 closed out, a net change of +1 holder.
- The largest Sanofi buyer in Q1 2026 was Morgan Stanley, an estimated $159M added.
- The largest Sanofi seller in Q1 2026 was Dodge & Cox, an estimated $1.26B sold.
Based on aggregated 13F filings for Q1 2026.